178 related articles for article (PubMed ID: 26685773)
1. Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation.
Braamse AM; Yi JC; Visser OJ; Heymans MW; van Meijel B; Dekker J; Syrjala KL
Biol Blood Marrow Transplant; 2016 Mar; 22(3):549-56. PubMed ID: 26685773
[TBL] [Abstract][Full Text] [Related]
2. Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell Survivors.
Farhadfar N; Weaver MT; Al-Mansour Z; Yi JC; Jim HSL; Loren AW; Majhail NS; Whalen V; Uberti J; Wingard JR; Lynch Kelly D; Syrjala KL
Transplant Cell Ther; 2022 Sep; 28(9):606.e1-606.e8. PubMed ID: 35662590
[TBL] [Abstract][Full Text] [Related]
3. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
Andrykowski MA; Bishop MM; Hahn EA; Cella DF; Beaumont JL; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
J Clin Oncol; 2005 Jan; 23(3):599-608. PubMed ID: 15659507
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with social functioning among long-term cancer survivors treated with hematopoietic stem cell transplantation as adolescents or young adults.
Walsh CA; Yi JC; Rosenberg AR; Crouch MV; Leisenring WM; Syrjala KL
Psychooncology; 2020 Oct; 29(10):1579-1586. PubMed ID: 32628342
[TBL] [Abstract][Full Text] [Related]
5. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
7. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.
Syrjala KL; Langer SL; Abrams JR; Storer B; Sanders JE; Flowers ME; Martin PJ
JAMA; 2004 May; 291(19):2335-43. PubMed ID: 15150205
[TBL] [Abstract][Full Text] [Related]
8. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.
Khera N; Chow EJ; Leisenring WM; Syrjala KL; Baker KS; Flowers ME; Martin PJ; Lee SJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):995-1003. PubMed ID: 21145404
[TBL] [Abstract][Full Text] [Related]
10. Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
Hong S; Zhao J; Wang S; Wang H; Lee JH; Farhadfar N; McGuirk JP; Savani BN; Shahrukh HK; Stiff P; Khera N; Hahn T; Loren AW; Jaglowski SM; Wood WA; Saber W; Cerny J; Holtan SG; Reynolds JM; Deol A; Jim H; Uberti J; Whalen V; Yi JC; Preussler J; Baker KS; Shaw BE; Devine S; Syrjala K; Majhail NS; Wingard JR; Al-Mansour Z
Transplant Cell Ther; 2023 Mar; 29(3):202.e1-202.e8. PubMed ID: 36427784
[TBL] [Abstract][Full Text] [Related]
11. Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation.
Rosenberg AR; Syrjala KL; Martin PJ; Flowers ME; Carpenter PA; Salit RB; Baker KS; Lee SJ
Cancer; 2015 Dec; 121(23):4250-7. PubMed ID: 26288023
[TBL] [Abstract][Full Text] [Related]
12. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).
Sun CL; Francisco L; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S
Blood; 2011 Oct; 118(17):4723-31. PubMed ID: 21821714
[TBL] [Abstract][Full Text] [Related]
13. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
14. Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study.
Wauben B; van der Poel MWM; Greevenbroek MMJ; van Yperen NC; Schram MT; van Boxtel MPJ; Sastry M; Simons SO; Stehouwer CDA; Dagnelie PC; Wesselius A; Schouten HC; Köhler S
Transplant Cell Ther; 2023 Jul; 29(7):468.e1-468.e8. PubMed ID: 36966872
[TBL] [Abstract][Full Text] [Related]
15. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.
Shankar SM; Carter A; Sun CL; Francisco L; Baker KS; Gurney JG; Weisdorf DG; Forman SJ; Robison LL; Grant M; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):834-9. PubMed ID: 17416780
[TBL] [Abstract][Full Text] [Related]
16. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
17. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
[TBL] [Abstract][Full Text] [Related]
18. Social support as a moderator of healthcare adherence and distress in long-term hematopoietic cell transplantation survivors.
Nørskov KH; Yi JC; Crouch ML; Fiscalini AS; Flowers MED; Syrjala KL
J Cancer Surviv; 2021 Dec; 15(6):866-875. PubMed ID: 33420905
[TBL] [Abstract][Full Text] [Related]
19. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
[TBL] [Abstract][Full Text] [Related]
20. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
Bishop MM; Beaumont JL; Hahn EA; Cella D; Andrykowski MA; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
J Clin Oncol; 2007 Apr; 25(11):1403-11. PubMed ID: 17416860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
